[HTML][HTML] Current status and future perspective of radiopharmaceuticals in China
J Hu, H Li, Y Sui, J Du - European Journal of Nuclear Medicine and …, 2022 - Springer
… The research and production of medical radioisotopes and radiopharmaceuticals in China …
use in China at the China Institute of Atomic Energy (CIAE). The first batch of 33 radioisotopes …
use in China at the China Institute of Atomic Energy (CIAE). The first batch of 33 radioisotopes …
Progress and application on the analysis of anthropogenic radionuclide 236U
S Yang, Y Guosheng, Z Jilong, L Min, M Lingling… - Acta Chimica …, 2021 - sioc-journal.cn
… State Nuclear Security Technology Center, Beijing 102401, China) Abstract Uranium-236 is
an important anthropogenic radionuclide except for the three main natural uranium isotopes, …
an important anthropogenic radionuclide except for the three main natural uranium isotopes, …
[HTML][HTML] Production review of accelerator-based medical isotopes
Y Wang, D Chen, R dos Santos Augusto, J Liang, Z Qin… - Molecules, 2022 - mdpi.com
… methods in the form of cyclotrons, linear accelerators and neutron generators. Finally, the
status of the production of medical isotopes in China is … methods for theranostic radioisotope …
status of the production of medical isotopes in China is … methods for theranostic radioisotope …
A review of anthropogenic radionuclide 236U: Environmental application and analytical advances
Y Shao, J Zhang, M Luo, D Xu, L Ma - Journal of Environmental …, 2022 - Elsevier
… 236 U is an anthropogenic radionuclide that is produced from nuclear reactions of 235 U(n,
γ) and 238 U(n, 3n). It has gained extensive attention in the field of environment, geology, …
γ) and 238 U(n, 3n). It has gained extensive attention in the field of environment, geology, …
Radioanalytical chemistry for nuclear forensics in China: Progress and future perspective
Y Liu, X Shao, W Bu, Z Qin, Y Ni, F Wu, C Yang… - Chinese Chemical …, 2022 - Elsevier
… and application of each technique is beyond … technique is frequently used. For instance, in
the concentration measurement of a specific radionuclide (eg, 239 Pu), a known amount of its …
the concentration measurement of a specific radionuclide (eg, 239 Pu), a known amount of its …
China's progress in radionuclide migration study over the past decade (2010–2021): Sorption, transport and radioactive colloid
Z Chen, S Wang, H Hou, K Chen, P Gao, Z Zhang… - Chinese Chemical …, 2022 - Elsevier
… In the context of China's HLW disposal, this review briefly summaries the progress of China's
… Overall, China has achieved clear progress in RN migration study over the past decade, …
… Overall, China has achieved clear progress in RN migration study over the past decade, …
Advance on monitoring of radioactivity in food in China and Japan after Fukushima nuclear accident
S Kong, B Yang, F Tuo, T Lu - Radiation Medicine and Protection, 2022 - mednexus.org
… industry in recent years, China has gradually revised the radionuclide activity limits on food
… nuclear accident, China and Japan have modified food monitoring methods and standards …
… nuclear accident, China and Japan have modified food monitoring methods and standards …
Advanced radionuclides in diagnosis and therapy for hepatocellular carcinoma
H Chen, M Teng, H Zhang, X Liang, H Cheng… - Chinese Chemical …, 2022 - Elsevier
… of radionuclide applications in medicine, radionuclide-based imaging and radiotherapy
are playing an … With the continuous progress of therapeutic methods and vectors, internal …
are playing an … With the continuous progress of therapeutic methods and vectors, internal …
Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals
F Li, Y Yang, J Liao, N Liu - Chinese Chemical Letters, 2022 - Elsevier
… There is a chemical conversion of astatine to polonium which will cause the radionuclide
to detach from the carriers, but the 211 Po daughter is not affected by nuclear recoil since it …
to detach from the carriers, but the 211 Po daughter is not affected by nuclear recoil since it …
[HTML][HTML] Advances in the application of radionuclide-labeled HER2 affibody for the diagnosis and treatment of ovarian cancer
X Hu, D Li, Y Fu, J Zheng, Z Feng, J Cai… - Frontiers in oncology, 2022 - frontiersin.org
… These measures will enable the clinical use of radionuclide-labeled … application of
radionuclide-labeled HER2 affibody in the imaging and treatment of ovarian cancer, including its …
radionuclide-labeled HER2 affibody in the imaging and treatment of ovarian cancer, including its …